Two-Year Clinical Outcomes With Drug-Eluting Stents for Diabetic Patients With De Novo Coronary Lesions: Results From a Real-World Multicenter Registry
Circulation - United States
doi 10.1161/circulationaha.107.730416
Full Text
Open PDFAbstract
Available in full text
Date
February 19, 2008
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)